Investments in clean energy are now seven times larger than in fossil energy in the Global South's electricity production, compared to an even split ten years ago. One-fifth of countries in the Global South have already surpassed wealthy nations on solar and wind power usage or electrification.
Enzymes are life's catalysts that enable the biochemical reactions that sustain all living organisms. Until now, science has struggled to explain exactly how these molecular machines work. The study offers a detailed explanation at the molecular level of how enzymes work.
Renewable energy expansion grew by 17 percent during 2024, with record installations of approximately 600 GW solar power and 125 GW wind power. Investments in renewable energy sources now outpace fossil fuels by 10 to 1, with more money in solar energy than all other power sources combined.
New research shows that sea turtle populations are increasing at 28 sites globally, while only five show declines. Conservation measures since the 1970s have transformed humans from hunters to protectors of these marine reptiles.
The Ervebo vaccine has demonstrated over 95 percent effectiveness against the Zaire strain of the Ebola virus. The vaccine is now used as a cornerstone in the fight against Ebola and has been successfully deployed in several African countries as a preventive measure.
Patients who developed an immune response from the personalized cancer vaccine have not yet experienced recurrence after more than three years of follow-up. The vaccine creates T cells that can live for up to 100 years and retain their ability to identify and fight cancer cells.
A total of 92 cases of deadly violence were recorded during 2024, which is 29 fewer cases than the previous year. The number of victims under 18 years decreased by 7 cases, from 17 to 10 cases compared to 2023.
The number of participation occasions in Swedish sports has increased by almost five million between 2019 and 2024. Football shows dramatic growth with a 23 percent increase since 2019. Several martial arts show positive development after difficult pandemic years.
The drug Tofersen shows good results for patients with ALS caused by mutations in the SOD1 gene, which accounts for 5-6 percent of all ALS cases. Several patients have experienced significant slowing of disease progression, and in some cases the disease has stabilized at the same level.